Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Philippines Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20091
20101
20181
20191
20201
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Amgen1
Eli Lilly and Company1
Incyte Corporation1
International Breast Cancer Research Foundation1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
R-Pharm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis13
Breast Neoplasms7
Carcinoma, Non-Small-Cell Lung3
Carcinoma2
Adenocarcinoma1
Anemia1
Breast Diseases1
Colonic Neoplasms1
Colorectal Neoplasms1
Rectal Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.